1. Signaling Pathways
  2. MAPK/ERK Pathway
    Stem Cell/Wnt
  3. ERK
  4. ERK Inhibitors

ERK Inhibitors

ERK

ERK1

ERK2

ERK5

ERK8

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

ERK Inhibitors & Activators
Product Name ERK ERK1 ERK2 ERK5 ERK8 Purity
PD98059  
ERK1
ERK2
    99.94%
SCH772984  
ERK1, IC50: 4 nM
ERK2, IC50: 1 nM
    98.69%
TBHQ
ERK
        ≥98.0%
Tauroursodeoxycholate sodium
ERK
        ≥98.0%
Ravoxertinib  
ERK1, IC50: 6.1 nM
ERK2, IC50: 3.1 nM
    99.75%
Aloisine A  
ERK1, IC50: 18 μM
ERK2, IC50: 22 μM
   
Honokiol  
ERK1
ERK2
    99.90%
Tauroursodeoxycholate
ERK
        ≥98.0%
Ulixertinib    
ERK2, IC50: 0.3 nM (at KM ATP (60 μM))
    99.92%
Temuterkib  
ERK1, IC50: 5 nM
ERK2, IC50: 5 nM
    99.85%
Astragaloside IV  
ERK1
ERK2
    ≥98.0%
Piperlongumine  
ERK1
ERK2
    99.19%
Lidocaine
ERK
        99.96%
BIX02189      
ERK5, IC50: 59 nM
  99.99%
FR 180204  
ERK1, Ki: 0.31 μM
ERK1, IC50: 0.51 μM
ERK2, Ki: 0.14 μM
ERK2, IC50: 0.33 μM
    99.59%
XMD8-92      
BMK1, Kd: 80 nM
  99.93%
AX-15836      
ERK5, IC50: 8 nM
  99.96%
Pluripotin  
ERK1, Kd: 98 nM
      98.86%
MK-8353  
ERK1, IC50: 23 nM
ERK2, IC50: 8.8 nM
   
KO-947  
ERK1
ERK2
    99.45%
Tizaterkib    
ERK2, IC50: 0.6 nM
    99.71%
VX-11e    
ERK2, Ki: 2 nM
    99.12%
LM22B-10
ERK
        99.72%
Mogrol  
ERK1
ERK2
    ≥98.0%
C16-PAF
ERK
        ≥98.0%
trans-Zeatin
ERK
        99.69%
Lidocaine hydrochloride
ERK
        99.81%
Pachymic acid
ERK
        ≥99.0%
BAY885      
ERK5, IC50: 35 nM
  99.15%
ERK5-IN-2      
ERK5, IC50: 0.82 μM
ERK5 MEF2D, IC50: 3 μM
  98.67%
XMD17-109      
ERK5, IC50: 162 nM
  ≥98.0%
Magnolin  
ERK1, IC50: 87 nM
ERK2, IC50: 16.5 nM
    99.98%
Methylthiouracil  
ERK1
ERK2
    ≥98.0%
ERK-IN-3  
ERK1
ERK2
    99.02%
Ravoxertinib hydrochloride  
ERK1, IC50: 6.1 nM
ERK2, IC50: 3.1 nM
    98.99%
DEL-22379    
ERK2, IC50: 0.5 μM
    99.76%
BIX02188      
ERK5, IC50: 810 nM
  99.59%
Corynoxeine  
ERK1
ERK2
    99.91%
Rineterkib  
ERK1
ERK2
    99.21%
ERK1/2 inhibitor 2  
ERK1
ERK2
    99.75%
Methylnissolin  
ERK1
ERK2
    99.64%
ERK5-IN-1      
ERK5, IC50: 87 nM
  99.92%
CHPG
ERK
        ≥99.0%
Longdaysin    
ERK2, IC50: 52 μM
    99.92%
2,5-Dihydroxyacetophenone  
ERK1
ERK2
    99.56%
CC-90003  
ERK1
ERK2
    99.41%
ERK1/2 inhibitor 1    
ERK2, IC50: 3.0 nM
    99.16%
Cearoin
ERK
        ≥98.0%
Deltonin  
ERK1
ERK2
    ≥99.0%
Omtriptolide
ERK
        98.23%
JWG-071      
ERK5, IC50: 88 nM
  99.78%
CK2/ERK8-IN-1        
ERK8, IC50: 0.5 μM
≥99.0%
Hypothemycin  
ERK1, Ki: 8.4 μM
ERK2, Ki: 2.4 μM
    ≥98.0%
Cafestol
ERK
        99.91%
ERK-IN-3 benzenesulfonate  
ERK1
ERK2
    98.06%
CHPG sodium salt
ERK
        99.17%
ERK2 IN-1    
ERK2, IC50: 7 nM
   
ERK-IN-2    
ERK2, IC50: 1.8 nM
   
Bohemine    
ERK2, IC50: 52 μM
    ≥98.0%
Enniatin B1
ERK
       
Enniatin B
ERK
       
Enniatin A1
ERK